Latest data from the Hong Kong Stock Exchange reveals that on April 15, HHLR Advisors, Ltd. purchased an additional 26.2 million shares of CStone PHARMA-B (02616). The transaction was executed at a price of HK$8.97 per share, amounting to a total investment of approximately HK$235 million. Following this acquisition, HHLR Advisors' total shareholding in the company has increased to 88.6645 million shares, representing a 6.01% stake.